Establishing a Distribution Network for COVID-19 Monoclonal Antibody Therapy Across a Large Health System During a Global Pandemic

Emergency authorized coronavirus disease 2019 (COVID-19)–neutralizing monoclonal antibodies can aid outpatients with mild to moderate COVID-19 infection. Many report barriers to adequate distribution and uptake. We present our model for distribution in a large health system as well as early lessons...

Descripción completa

Detalles Bibliográficos
Autores principales: Bariola, J Ryan, McCreary, Erin K, Khadem, Tina, Snyder, Graham M, Wadas, Richard J, Nace, David A, White, Douglas B, Yealy, Donald M, Schmidhofer, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083628/
https://www.ncbi.nlm.nih.gov/pubmed/34322560
http://dx.doi.org/10.1093/ofid/ofab151
_version_ 1783686016188547072
author Bariola, J Ryan
McCreary, Erin K
Khadem, Tina
Snyder, Graham M
Wadas, Richard J
Nace, David A
White, Douglas B
Yealy, Donald M
Schmidhofer, Mark
author_facet Bariola, J Ryan
McCreary, Erin K
Khadem, Tina
Snyder, Graham M
Wadas, Richard J
Nace, David A
White, Douglas B
Yealy, Donald M
Schmidhofer, Mark
author_sort Bariola, J Ryan
collection PubMed
description Emergency authorized coronavirus disease 2019 (COVID-19)–neutralizing monoclonal antibodies can aid outpatients with mild to moderate COVID-19 infection. Many report barriers to adequate distribution and uptake. We present our model for distribution in a large health system as well as early lessons learned.
format Online
Article
Text
id pubmed-8083628
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-80836282021-05-03 Establishing a Distribution Network for COVID-19 Monoclonal Antibody Therapy Across a Large Health System During a Global Pandemic Bariola, J Ryan McCreary, Erin K Khadem, Tina Snyder, Graham M Wadas, Richard J Nace, David A White, Douglas B Yealy, Donald M Schmidhofer, Mark Open Forum Infect Dis Brief Report Emergency authorized coronavirus disease 2019 (COVID-19)–neutralizing monoclonal antibodies can aid outpatients with mild to moderate COVID-19 infection. Many report barriers to adequate distribution and uptake. We present our model for distribution in a large health system as well as early lessons learned. Oxford University Press 2021-03-26 /pmc/articles/PMC8083628/ /pubmed/34322560 http://dx.doi.org/10.1093/ofid/ofab151 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Brief Report
Bariola, J Ryan
McCreary, Erin K
Khadem, Tina
Snyder, Graham M
Wadas, Richard J
Nace, David A
White, Douglas B
Yealy, Donald M
Schmidhofer, Mark
Establishing a Distribution Network for COVID-19 Monoclonal Antibody Therapy Across a Large Health System During a Global Pandemic
title Establishing a Distribution Network for COVID-19 Monoclonal Antibody Therapy Across a Large Health System During a Global Pandemic
title_full Establishing a Distribution Network for COVID-19 Monoclonal Antibody Therapy Across a Large Health System During a Global Pandemic
title_fullStr Establishing a Distribution Network for COVID-19 Monoclonal Antibody Therapy Across a Large Health System During a Global Pandemic
title_full_unstemmed Establishing a Distribution Network for COVID-19 Monoclonal Antibody Therapy Across a Large Health System During a Global Pandemic
title_short Establishing a Distribution Network for COVID-19 Monoclonal Antibody Therapy Across a Large Health System During a Global Pandemic
title_sort establishing a distribution network for covid-19 monoclonal antibody therapy across a large health system during a global pandemic
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083628/
https://www.ncbi.nlm.nih.gov/pubmed/34322560
http://dx.doi.org/10.1093/ofid/ofab151
work_keys_str_mv AT bariolajryan establishingadistributionnetworkforcovid19monoclonalantibodytherapyacrossalargehealthsystemduringaglobalpandemic
AT mccrearyerink establishingadistributionnetworkforcovid19monoclonalantibodytherapyacrossalargehealthsystemduringaglobalpandemic
AT khademtina establishingadistributionnetworkforcovid19monoclonalantibodytherapyacrossalargehealthsystemduringaglobalpandemic
AT snydergrahamm establishingadistributionnetworkforcovid19monoclonalantibodytherapyacrossalargehealthsystemduringaglobalpandemic
AT wadasrichardj establishingadistributionnetworkforcovid19monoclonalantibodytherapyacrossalargehealthsystemduringaglobalpandemic
AT nacedavida establishingadistributionnetworkforcovid19monoclonalantibodytherapyacrossalargehealthsystemduringaglobalpandemic
AT whitedouglasb establishingadistributionnetworkforcovid19monoclonalantibodytherapyacrossalargehealthsystemduringaglobalpandemic
AT yealydonaldm establishingadistributionnetworkforcovid19monoclonalantibodytherapyacrossalargehealthsystemduringaglobalpandemic
AT schmidhofermark establishingadistributionnetworkforcovid19monoclonalantibodytherapyacrossalargehealthsystemduringaglobalpandemic

Ejemplares similares